GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Price-to-Free-Cash-Flow

Tibet Aim Pharm (SZSE:002826) Price-to-Free-Cash-Flow : 10.11 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Price-to-Free-Cash-Flow?

As of today (2024-05-27), Tibet Aim Pharm's share price is ¥9.07. Tibet Aim Pharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.90. Hence, Tibet Aim Pharm's Price-to-Free-Cash-Flow Ratio for today is 10.11.

The historical rank and industry rank for Tibet Aim Pharm's Price-to-Free-Cash-Flow or its related term are showing as below:

SZSE:002826' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.68   Med: 23.54   Max: 23200
Current: 10.11

During the past 10 years, Tibet Aim Pharm's highest Price-to-Free-Cash-Flow Ratio was 23200.00. The lowest was 8.68. And the median was 23.54.

SZSE:002826's Price-to-Free-Cash-Flow is ranked better than
81.04% of 517 companies
in the Drug Manufacturers industry
Industry Median: 23.4 vs SZSE:002826: 10.11

Tibet Aim Pharm's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥0.27. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥0.90.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Tibet Aim Pharm was 63.70% per year.

During the past 10 years, Tibet Aim Pharm's highest 3-Year average Free Cash Flow per Share Growth Rate was 189.30% per year. The lowest was 20.00% per year. And the median was 104.65% per year.


Tibet Aim Pharm Price-to-Free-Cash-Flow Historical Data

The historical data trend for Tibet Aim Pharm's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Price-to-Free-Cash-Flow Chart

Tibet Aim Pharm Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 28.79 25.06 29.97

Tibet Aim Pharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.64 20.46 45.18 15.16 9.64

Competitive Comparison of Tibet Aim Pharm's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Aim Pharm's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Aim Pharm's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Aim Pharm's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tibet Aim Pharm's Price-to-Free-Cash-Flow falls into.



Tibet Aim Pharm Price-to-Free-Cash-Flow Calculation

Tibet Aim Pharm's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=9.07/0.897
=10.11

Tibet Aim Pharm's Share Price of today is ¥9.07.
Tibet Aim Pharm's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.90.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Tibet Aim Pharm  (SZSE:002826) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Tibet Aim Pharm Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Aim Pharm (SZSE:002826) Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines